NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

So far, this has worked for me.

5 Years: Up 368.75% as of Friday, for 5 years, hasn't got me upset. Obviously it fluctuated massively during that period and was at times substantially down for many investors. Compared to MRK and IBB, that's quite good for me. Timing stocks is difficult however, so I try to buy when stocks I like are down, and I never chase them up. As I am a long-term investor, but I don't buy at the very start of these companies, but when they are distressed, this is the most meaningful time-range for me both factually and with regard to measuring potential.


YTD: Up 7.14% YTD. It has been relatively flat YTD, but bouncing around flat and currently, obviously trending upward in anticipation of Dr. Liau's presentation at SNO. This is not bad compared to where the markets have been this year for many investors.


3 Months: Up 19.05% is not bad for 3 months. That is especially true compares to where the markets have been this year.


And as for the entire life of the investment or longer periods, well, we are waiting for final news and ultimate appreciation from having a real product. But that kind of depreciation from first offerings to pre-TLD, pre-product, pre-revenue valuations years later is usually hugely down for most of these microcap biotechs, especially those that go it alone. The market is a cruel master and there are a lot of manipulators out there who play with these stocks to benefit their own pockets at the expense of the investors and the companies. That's just a reality. Plus the volatility ranges from people worried about tying up their capital, to people who get quite emotional about the volatility and from moments of euphoria to despair about the pricing. It's an unfortunate reality of the ride on this side of the markets. Obviously, total loss is always a possibility for these companies. But as you reveal results, the risk calculations can change rapidly. We already know they have significantly positive results with OS, for both newly diagnosed and recurrent glioblastoma, so that's a very encouraging sign that they could get approval and have a substantial opportunity to do both deals and to earn revenues from their hard work of many years. We'll have to see how it all works out, but obviously I'd not be invested if I thought it would not turn out successfully, and it has been very positive for me.